Chad M. House

Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients.

Chad M. House, W. B. Nelson, Glenn A. Nickele, Imdad Ahmed +1 more

2011European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology3 citations Open access

Semantic Scholar

Chad M. House

Most-cited papers

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.

Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation

Manufacturer-provided effective orifice area index charts and the prevention of prosthesis-patient mismatch.

How reliable is an effective orifice area indexed chart?

Normalization of Left Ventricular Ejection Fraction and Incidence of Appropriate Antitachycardia Therapy in Patients With Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Death.

Anatomic versus Effective Orifice Area in a Bicuspid Aortic Valve

Gender differences in primary mitral regurgitant volumes at specific regurgitant fractions as assessed by magnetic resonance imaging

The Association Between Cardiac Rehabilitation Attendance and Hospital Readmission

Sex difference in mitral valve prolapse regurgitant volume is resolved by normalization of regurgitant volume to left ventricular end-diastolic volume

Inappropriate noise detection in Tendril family pacing leads

Performing Accurate Standard 12 Lead ECGs on patients with Burns to the Chest.

Safety of coronary angiography and percutaneous coronary intervention in patients on uninterrupted warfarin therapy: a meta-analysis

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death

Abstract 16457: Inappropriate Noise Sensing is a Common Finding in St Jude Tendril Leads

Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death†

Feasibility of an Elective Cardioversion Service Led by Advanced Practice Providers without Direct Cardiologist Supervision

Mitral valve area by the pressure half-time method does not correlate with mean gradient in mitral valve repair patients.

Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB)

Sudden cardiac arrest in apical hypertrophic cardiomyopathy

Safety of continuing warfarin therapy in patients undergoing cardiac resynchronization therapy device implantation

Letter by House et al regarding article, "Prosthesis-patient mismatch in bovine pericardial aortic valves: evaluation using 3 different modalities and associated medium-term outcomes".

Abstract 15027: Normalization of Left Ventricular Ejection Fraction is Associated With the Absence of Appropriate Anti-Tachycardia Therapy in Patients Receiving Implantable Defibrillators for the Primary Prevention of Sudden Death

Aortic pseudoaneurysm in a patient with rheumatoid arthritis.

Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation

Abstract 3554: Safety of Cardiac Resynchronization Therapy Device Implantation in Patients With Uninterrupted Chronic Warfarin Therapy

Prevalence and impact of cognitive impairment assessed by Mini-Cog in hospitalized cardiac rehabilitation referrals

Questions Regarding Recent Study Comparing Mitral Regurgitant Volume Between Proximal Flow Convergence and Volumetric Methods: The Importance of Sex Differences.

ASSESSING FOR COGNITIVE IMPAIRMENT WITH THE MINI-COG IN INPATIENT CARDIAC REHABILITATION REFERRALS AT A TERTIARY MEDICAL CENTER

Prevalence and Doppler Echocardiographic Characteristics of Normally Functioning Mitral Prostheses with Mean Gradient ≥10 mmHg.

MANAGEMENT OF FUNCTIONAL SPRINT FIDELIS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEADS AT CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATOR GENERATOR REPLACEMENT: AN ALTERNATIVE APPROACH FOR PREVENTION OF INAPPROPRIATE SHOCKS CAUSED BY LEAD FAILURE

51 Early Discharge With Next Day Stress Testing in Low Risk Chest Pain Patients Presenting to the Emergency Department is Feasible

Reply

Ultra low-dose single photon emission computed tomography myocardial perfusion imaging

CHRONIC KIDNEY DISEASE IS A SIGNIFICANT RISK FACTOR OF POCKET HEMATOMA FORMATION AFTER PACEMAKER AND IMPLANTABLE CARDIOVERTER- DEFIBRILLATOR PLACEMENT INDEPENDENT OF ANTICOAGULATION AND ANTIPLATELET AGENTS

Abstract 2440: Continuation of Warfarin is Superior to Holding Warfarin With or Without Bridging Therapy in Patients Undergoing Pacemaker and Defibrillator Placement